A team from UT Southwestern (UTSW) has found that a significant number of breast cancer patients have higher levels of the ZMYND8 gene, making it a potential target for immunotherapies and precision...
ONC is currently recruiting additional demonstration sites for phase four of its Sync for Genes pilot project, an effort to standardize and improve genomic data sharing between laboratories, providers,...
Researchers from the Johns Hopkins departments of oncology and pathology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University (JHU) School of Medicine, and 18 other organizations...
Using data from RNA sequencing, a team from the Icahn School of Medicine at Mount Sinai has detected three molecular subtypes of Alzheimer’s disease that could advance precision medicine...
Analyzing genomic data from diverse populations could improve prostate cancer risk scores and enable early detection of the disease, a study published in Nature Genetics revealed.
Prostate cancer is...
A new tool that focuses on RNA could accelerate the development of precision medicine treatments for incurable diseases, including a type of metastatic breast cancer, according to a study published in...
Researchers at the Perelman School of Medicine at the University of Pennsylvania have received a $4.8 million grant from the National Institute on Aging (NIA) to study the genetics of Alzheimer’s...
NIH’s All of Us precision medicine research program is beginning to return genetic results to participants, with individuals now able to receive information about their genetic ancestry and...
Researchers from Penn Medicine have discovered a new biomarker that identifies which patients with aggressive lymphoma won’t respond to a precision medicine treatment called ibrutinib.
The...
Researchers at The Ohio State University Wexner Medical Center are creating a precision medicine method to determine patients’ genetic risk of developing glaucoma, with the goal of reducing...
Children’s Hospital of Pennsylvania (CHOP) and Gustave Roussy, a cancer research organization based in France, have received a $1.3 million grant from neuroblastoma clinical research charities to...
While the promises of precision medicine in healthcare are seemingly boundless, the industry has had to overcome several challenges to integrating these approaches with everyday clinical care.
From...
A precision medicine treatment that involves correcting an underlying genetic mutation led to the reversal of a case of type 1 diabetes, according to a study published in the New England Journal of...
Broad-based genetic testing could identify inherited genetic mutations and accelerate precision medicine therapies for patients with cancer, according to a study published in JAMA Oncology.
Hereditary...
A deep learning algorithm was able to accurately analyze tumor data and recommend the best possible treatments for patients, potentially accelerating cancer precision medicine, according to a study...
After analyzing the genomic data of men of different races, researchers believe that a combination of socioeconomic and biological factors may contribute to racial disparities in prostate cancer...
A team at the Perelman School of Medicine at the University of Pennsylvania will leverage artificial intelligence to find patterns in genetic, imaging, and clinical data from over 60,000...
UC San Francisco (UCSF) is using a $1 million grant to build a first-of-its-kind diagnostic center that will aim to use precision medicine methods to find targeted therapies for type 1 diabetes.
The...
Precision medicine has emerged in recent years as a potential way to deliver personalized, comprehensive care to patients with a wide range of diseases.
In just the last few months, researchers have...
NIH is funding a nationwide study involving 20 research centers to better understand unusual types of diabetes, which could accelerate precision medicine for the condition.
The Rare and Atypical...
